CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Elysium Healthcare Holdings 3 Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Elysium Healthcare Holdings 3 Ltd.
2 Imperial Place
Maxwell Road
Borehamwood, Hertfordshire  WD6 1JN  United Kingdom
This is a Subsidiary, click here for the Parent Company
Business Summary
Elysium Healthcare Holdings 3 Ltd. is a subsidiary of Elysium Healthcare Holdings 2 Ltd. ("Elysium"). Elysium is an operator of behavioral healthcare facilities in England and Wales. The Company offers medium-to-low secure, rehabilitation and recovery and complex care, acute, learning disabilities and neurological inpatient services to people suffering from a variety of behavioral health conditions across England and Wales. The Company is majority-owned by funds managed and advised by BC Partners.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
----Yes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes----


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024